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kbstract Individual protein kinase C isozymes have been shown 
Io play different roles in mediating proliferation, differentiation 
and transformation, but it is not known to what extent these 
effects involve induction of expression of particular genes. To 
explore the differential gene expression that might be induced by 
activation of different PKC isozymes, we stably transfected NIH 
3T3 cells with expression vectors that encode the isozymes PKC- 
~, -Eli, -V, -~i, -c, -~ and -~l. Using differential display-reverse 
transcription-polymerase chain reaction we isolated a small 
eDNA that encodes a portion of the primary response gene, ST2 
(also referred to as T1 or DER4), and we confirmed by RNA blot 
studies that ST2fYI expression is differentially regulated by PKC 
isozymes. ST2/TI mRNA is undetectable in the unstimulated 
parental NIH 3T3 cells that express only the a isozyme of PKC, 
but it can be induced by phorbol ester treatment. Clones that 
overexpress PKC-a, -5 or -e similarly do not express ST2/TI 
until they are stimulated with phorbol esters, which induces ex- 
pression of ST2/TI with kinetics similar to wild-type NIH 3T3 
but to different extents. In contrast, ST2/TI mRNA is already 
present in unstimulated cells that overexpress PKC-~III, -V, -~ 
and -~l, but phorbol ester greatly enhances ST2frl expression in 
these cells. These results suggest a differential role for PKC 
isozymes in mediating the ST2ff l  expression that is induced by 
growth stimuli. 
Key words': Protein kinase C (mouse); Isozyme; Differential 
display; ST2; T1; Expression 
I. Introduction 
The protein kinase C (PKC) isozymes comprise a family of 
at least eleven different serine/threonine kinases that are impli- 
cated in a variety of cellular responses including proliferation, 
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differentiation, gene expression, membrane transport as well as 
secretion of hormones and neurotransmitters (see [1-3] for re- 
views). Initially, PKC was described as a Ca 2+- and phospho- 
lipid-dependent serine/threonine kinase [4,5], and later it was 
shown to be the major intracellular eceptor for the tumor- 
promoting phorbol esters [6,7]. cDNA cloning and careful ex- 
amination of the encoded proteins has revealed that the mem- 
bers of the PKC family can be classified into three major 
groups, namely, classical, cPKCs-c~, -/31, -1~II and -y, [8]; novel, 
nPKCs-~, -e, -/7, -0, and -¢t [9-15]; and atypical, aPKCs -5 and 
-t (the human counterpart of mouse aPKC-2) [10, 1618]. Only 
the cPKCs require Ca 2+ for activity. 
Most PKC isozymes appear to be quite similar in basic struc- 
tural features and in means of activation, since they translocate 
from the cytosol to different intracellular sites upon activation 
with diacylglycerol (DAG) and phospholipids [2]. Phorbol es- 
ters, such as 12-O-tetradecanoylphorbol-13-acetate (TPA) 
mimic DAG in that they can bind and activate all PKCs, except 
the aPKCs, by substituting for endogenous DAG [6,7]. How- 
ever, the different isozymes exhibit distinct tissue and cellular 
localization [19-22]. Furthermore, only certain isozymes are 
involved in particular physiological functions. For example, 
PKC-c~ and -~, but not PKC-]3II, -e, -t/or -5, mediate differen- 
tiation of myeloid 32D cells to mature macrophages [23]. What 
is more, overexpression of PKC-e in NIH/3T3 cells leads to 
oncogenic transformation [24,25], whereas overexpression of
PKC-J inhibits proliferation in different cell systems [24,26]. 
The highly diverse biological actions of PKC clearly call for a 
determination of the specific biochemical functions of each 
PKC isoform. 
In an early attempt o dissect he transcriptional responses 
to activation of the different PKC isozymes, Hata et al. [27] 
showed that overexpression f PKC-~, -fill, or -6 in 3Y1 cells 
enhanced transcription of c-jun, [which contains an upstream 
TPA-responsive lement (TRE)], while overexpressed PKC-y 
did not. PKC-y did, however, induce transcriptional ctivation 
of genes that contain upstream serum response lements (SRE), 
as did all the other PKC isozymes tested. These experiments 
suggested that activation of the different PKC isozymes results 
in distinct and isozyme-specific transcriptional ctivities. To 
extend these studies, we used the method of differential display 
reverse-transcription polymerase chain reaction (DDRT-PCR, 
[28,29]) on NIH 3T3 cells that stably overexpress PKC-~, -fill, 
-~', -J, -e, -5 and -r/ [22,24]. To our knowledge, the data pre- 
sented in this paper are the first comparisons of gene induction 
by 7 PKC isozymes within the same cellular environment. 
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2. Materials and methods 
2.1. Expression vectors 
Overexpression f the 7 PKC isozymes [23,24] was achieved using 
pMTH and pLTR expression vectors, pMTH-flII,-6, and -( were con- 
structed by inserting the corresponding blunt-ended cDNAs into the 
blunt-ended BamHI site of pMTH (kindly provided by Dr. G. Shen- 
Ong) which contains the mouse metallothionine promoter and the neo- 
mycin resistance gene as a selectable marker [30]. pLTR-=, which over- 
expresses PKC-c~ in the expression vector pLTR, and pLTR were ob- 
tained from Dr. N. Mazurek. pLTR contains the Rous sarcoma virus 
LTR enhancer and promoter and the mycophenolic a id resistance gene 
as a selectable marker [32]. pLTR-e and -r/were constructed by insert- 
ing the PKC-e and -r/cDNA EcoRI fragments into pLTR. 
2.2. Generation of overexpressing cell lines 
Our clone of NIH 3T3 cells expressed only PKC-~ until it was 
transfected with each PKC expression vector, as described elsewhere 
[22-24]. Transfected cells were selected in the appropriate medium, and 
12 resistant clones from each transfection were randomly screened for 
PKC protein expression. The clone that displayed the highest level of 
protein expression for each isoform was used in the following experi- 
ments. The PKC-y-overexpressing NIH 3T3 cells (3T3-SG-gl0) were 
a kind gift from Dr. J. Silvio Gutkind [33]. 
2.3. PKC kinase assays 
PKC activity was determined on cell lysates that were partially puri- 
fied over a DEAE column as described [23]. 5 x 106 cells were lysed in 
500 ~tl lysis buffer that contained 30 mM Tris pH 7.5, 2 mM EDTA, 
2 mM EGTA, 2 mM dithiothreitol, 0.5 mM PMSF and 5 mM ben- 
zamidine and sonicated on ice for I0 s. The insoluble fraction was 
removed by centrifugation at 14,000 x g for 10 min. 10/.tl oflysate was 
added on ice to 40/.tl of assay mix that contained 20 mM Tris-HCl pH 
7.5, 1 mM CaCI2, 10 mM MgAc, 10 nM TPA, 80 #g/ml phosphati- 
dylcholine, 20 pg/ml phosphatidylserine, I0/tM ATP/[7/-32p]ATP (spe- 
cific activity 20 Ci/mmol) and 0.2 mg/ml PKC-ct substrate peptide 
(BRL). The reactions were incubated at 30°C for 10 min, and 25 ml of 
each reaction were spotted onto a Whatman DE-52 paper. The paper 
was washed three times with 0.1 M H3PO4 and once with acetone, air 
dried and counted. Background (phospholipid-independent) ki ase ac- 
tivity was assayed under identical conditions without TPA and phos- 
pholipid and subtracted from the total kinase activity measured in the 
presence of TPA and phospholipid. 
2.4. RNA isolation and Northern blot analysis 
Poly(A) ÷ RNA from clones of NIH 3T3 cells that overexpressed the 
different PKC isozymes was isolated following overnight starvation 
and stimulation with TPA for different ime points as previously de- 
scribed [19]. 5 ltg of each RNA were fractionated on 1% agarose gels 
containing formaldehyde. The RNA was transferred to Hybond-N 
nylon membranes (Amersham) by capillary blotting and hybridized 
overnight with 3 x 10 6 cpm/ml of random-primed cDNA probes, 
washed at high stringency (0.2× SSC, 0.1% SDS at 65°C) and exposed 
to Kodak XAR-2 film overnight or for 4 h in the case of glyceraldehyde- 
3-phosphate-dehydrogenase (GAPDH). For sequential hybridization 
of the same blots with different DDRT-PCR-generated probes, mem- 
branes were stripped with boiling water. After hybridization with these 
short cDNA probes, the blots were probed with a full-length cDNA of 
TI [36] and with a probe specific for the 'housekeeping' gene GAPDH 
[34] to confirm the identity of the DDRT-PCR probe and to normalize 
for the amount of mRNA loaded in each lane, respectively. 
2.5. Differential display 
1 ,ug of mRNA from each of the different NIH 3T3 lines was reverse 
transcribed with the Superscript kit (BRL) following the manufac- 
turer's protocol, using the oligonucleotide 5' Tu-CA 3' as a primer. 
DDRT-PCR was performed with 10 ng of single-stranded cDNA in 
each 50/~1 reaction using Taq Polymerase (BRL) and the 5' Tu-CA 3' 
oligonucleotide as an anchor primer combined with an 10-mer arbitrary 
primer, taken from a primer set (primers OPA-01 to OPA-20, Operon 
Biotechnology Inc. Alameda, CA). dNTP concentration was 20/.tM 
each, supplemented with 5 ltCi of [cc-33p]dATP (3000 Ci/mmol; ICN 
Biomedicals, Inc.). Each of the 35 cycles of PCR included 1 rain anneal- 
ing at 40°C, 30 s extension at 72°C and 30 s denaturing at 94°C. The 
initial denaturating step lasted 2 min, the final extension 5 min. The 
reaction products were resolved on a 6% polyacrylamide s quencing 
gel. After electrophoresis the gel was dried on 3MM Whatman chrom- 
atography paper and exposed to a Kodak XAR-2 film overnight. Bands 
of interest were cut out of the gel, and the DNA was recovered by 
boiling the gel slice in H20 for 15 min and subsequent e hanol precip- 
itation in the presence of 0.3 M sodium acetate. DNA fragments were 
reamplified by PCR with the same primers used for the display PCR. 
2.6. Cloning and sequencing 
20 ng of each reamplified DNA fragment were phosphorylated using 
T4-kinase, ligated into 10 ng of Sinai-digested pBS (Stratagene), and 
the resulting DNA was transfected into electrocompetent DHIOB cells 
(BRL) using electroporation. Positive colonies were identified by col- 
ony hybridization using the reamplified DNA fragment as a probe and 
confirmed by restriction digestion of DNA isolated from positive 
clones. Restriction fragments were purified on a 1% low melting point 
agarose gel and used as probes on Northern blots. DNAs that detected 
differentially expressed mRNAs were sequenced with the Sequenase 
sequencing kit (United States Biochemical Corporation) according to 
the manufacturer's protocol. 
3. Results 
Western blots of the overexpressing cell lines have been pub- 
lished elsewhere [22,24]. To ensure that the immunologically 
detected PKCs in each stably transfected, overexpressing clone 
of N IH 3T3 cells showed kinase activity, kinase assays were 
performed on cell lysates that had been partially purified as 
described [23]. The results of these assays, presented in Table 
1, show that all the overexpressed PKC isozymes are active 
kinases. 
To study TPA-induced genes in the different overexpressers, 
the cell lines were transferred to serum-free medium overnight 
and then treated with 100 nM TPA for 0, 15, 90, or 300 min. 
At each time point the cells were harvested, and poly(A) + RNA 
was isolated as described previously [19]. 1/ lg poly(A) + RNA 
was reverse transcribed and used for the subsequent display 
PCR, using the oligonucleotide 5' T l l -CA  3' as an anchor 
primer combined with the oligonucleotide 5' TGCCGAGCTG 
3' (OPA-02) as an arbitrary primer. 
As shown in Fig. 1, several amplified bands appeared to be 
differentially expressed in the different PKC overexpressers. 
Eight bands that were of potential interest (indicated by down- 
ward arrows) were excised, eluted and reamplified. The prod- 
Table 1 
PKC kinase assays of NIH 3T3 wild type 
PKC isozymes 
and lines that overexpress 
Cell line PKC activity 
cpm/mg protein 
NIH 3T3 32,000 
3T3-LTR-~2 58,000 
3T3-MTH-/310 72,000 
3T3-SG-yl0 64,000 
3T3-MTH-69 58,000 
3T3-LTR-e2 78,000 
3T3-MTH-~'4 43,000 
3T3-LTR-r/1 74,000 
The kinase activity was measured in cell lysates partially purified by 
stepwise lution of DEAE-52 columns as described [23] and is expressed 
as cpm 32p incorporation i to the PKC-~ substrate peptide per/~g lysate 
protein. 
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Fig. I. Autoradiograph of PCR products resolved on a 6% poly- 
acrylamide gel under denaturing conditions, cDNAs of either wild-type 
NIH 3T3 (3T3) or the PKC overexpressers (a  indicated by the Greek 
letters on the top of the figure) which were stimulated with 100 nM TPA 
for 0, 15, and 90 min or 5 h (as indicated on the top) were used for the 
different reactions. The fragments that appeared to be differentially 
expressed and that were subsequently excised are indicated by down- 
ward-pointing arrows. 
ucts of the reamplification were electrophoresed on an agarose 
gel (not shown). While most of the reamplifications resulted in 
a single DNA fragment that appeared to be of the same size as 
the original display PCR product, some reactions yielded frag- 
ments that did not amplify well (e.g. fragment 7) and some 
yielded fragments that were multiple (e.g. fragment 1) or incon- 
sistent in size with the original DNA. These were not used for 
further experiments. 
To evaluate which of the isolated DNAs represent differen- 
tially expressed RNA, the remaining six reamplified DNA frag- 
ments were labeled by random priming and used to probe 
selected Northern blots of RNA. Our experience indicated that 
it is desirable to perform this screening test early, since only one 
(fragment 9) of the six DNAs isolated from the display gel was, 
in fact, differentially expressed Two (fragments 3 and 10) did 
not hybridize on Northern blots and therefore were discarded 
as artifacts (probably due to contamination with genomic 
DNA); one (fragment 8) encoded a portion of the 18S ribo- 
somal RNA, and two (fragments 2 and 4) were expressed essen- 
tially equally in all samples. 
The single differentially expressed fragment was cloned and 
sequenced. The sequence of the 427-bp fragment showed 100% 
identity to the murine ST2 gene [35], also referred to as T1 [36] 
or DER4 [37]. Northern blots of RNA from overexpressing 
clones of NIH 3T3 that had been stimulated with TPA for 0, 
15, 90, or 300 min were probed with the cloned and sequenced 
PCR fragment and subsequently, to avoid any misleading arti- 
facts due to a PCR-derived probe, with a full-length T1 cDNA 
191 
[36]. Both hybridizations yielded virtually identical results. As 
shown in Fig. 2, fragment 9 or ST2/T1 is expressed predomi- 
nantly as a 3.2-kb mRNA, with an additional mRNA of ca. 
6 kb visible in the samples that show high expression. Expres- 
sion can be induced in wild-type NIH 3T3 cells by TPA treat- 
ment, reaching amaximum after 5 h. Similar esults can be seen 
in the PKC-~, -5 and -e overexpressers. 
In the clones that overexpressed PKC-fllI, -~', -r/, and -(, 
ST2/T1 is expressed even in the absence of TPA, but expression 
is induced to even higher levels with TPA. Interestingly, overex- 
pression of the cPKCs (flII and y) results in a peak of ST2/TI 
expression at 90 min and a clear decline after 5 h, while the 
nPKCs (~ and r/) as well as aPKC-( show either similar levels 
at 90 and 300 rain (( and ~/) or highest levels of induction at 
300 rain (e), similar in respect o the time course, but not to 
signal intensity, to wild-type NIH 3T3. We also probed bulk 
cultures of PKC overexpressers with the T 1 probe and obtained 
results that were similar to those from the cloned cell lines 
shown in Fig. 2 (data not shown). 
4. Discussion 
ST2/T1 has been described as a primary response gene to 
growth stimuli n BALB/c 3T3 cells and as a p21H-r"s-inducible 
gene in NIH 3T3 fibroblasts [35,36]. Its expression can be in- 
duced by serum, growth factors and TPA and peaks after 6-10 
h [35,38]. ST2/T1 belongs to the carcinoembryonic antigen fam- 
ily of tumor markers and shows high homology to the IL-1 
receptor type 1 and 2. It is expressed predominantly asa 2.7-kb 
mRNA [37,38], and its gene product, a protein with an appar- 
ent molecular weight of 50-70 kDa (due to N-glycosylation 
heterogeneity) is secreted into the medium [38]. Another ca. 
5.5-kb transcript [38,39], termed ST2L, seems to be an integral 
membrane protein. Its ligand, however, is still unknown. As 
shown in Fig. 2, we find bands of the expected size for both 
transcripts on the Northern blots, The difference from the sizes 
reported in the literature (we find them to be ca. 3.2-kb and 
6-kb transcripts) is most likely due to the use of different RNA 
size markers. Our results confirm and extend the published 
findings that ST2/T1 is a PKC-inducible gene. It can be induced 
by TPA treatment of cells, but it is expressed at significantly 
higher levels if specific members of the PKC family are overex- 
pressed. The fact that NIH 3T3 cells that overexpress PKC-E, 
-(, and -r/, the three isoforms that seem to induce transforma- 
tion of NIH 3T3 ([24,40] and Goodnight and Mischak, unpub- 
lished), show a strong and prolonged ST2/TI induction after 
PKC activation by TPA, makes it tempting to speculate that 
ST2/T1 might contribute to PKC-mediated transformation 
of NIH 3T3. This hypothesis correlates with reports of 
Werenskiold et al. [36] that ST2/T1 is an inducible gene and that 
ST2/T1 might be involved in the process of tumorgenicity. 
Experiments to test this notion involving the overexpression f 
ST2/TI in NIH 3T3 cells are underway and will be reported 
elsewhere. 
Our results also show that PCR display can be a powerful 
tool to pinpoint genes that are induced by only certain PKC 
isozymes. When comparing Figs. 1 and 2, the patterns of ST2/ 
T1 induction can be seen both in the DDRT-PCR (in the bands 
indicated by arrows 3, 9 and 10), and, with similar kinetics, on 
the Northern blot. It is apparent that bands 3, 9 and 10 on the 
differential display (Fig. l) are likely to represent the same gene 
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Fig. 2. Expression of ST2/T1 in NIH 3T3 cells. Northern blots of either wild-type NIH 3T3 or the different overexpressers that were stimulated with 
100 nM TPA for the time (min) indicated on the top. 5/ag mRNA were loaded per lane. The blots were probed with cloned lane 9 product (panel 
A) and then with full-length T1 cDNA [36] (panel B). The size and position of RNA size standards are indicated on the right. The hybridization 
of these Northerns blots with GAPDH (to normalize for the amount of mRNA loaded in each lane) is shown below the lane 9 and T 1 hybridization 
results. 
transcript (ST2/T1), and bands 2 and 11 may also represent 
identical transcripts of a different gene. Variability in cloning 
of the different isolates may have contributed to the fact that 
only band 9 yielded usable data that permitted i entification of
the differentially expressed transcript as ST2/T1. It should be 
pointed out that the quantitative differences in ST2FF1 expres- 
sion seen in several PKC overexpressers do not necessarily 
reflect direct activation of this gene's expression by PKC itself. 
Instead, they could be due to modulators downstream ofPKC. 
At first glance, the data on PKC-( in Fig. 2 suggest hat 
PKC-( can be activated by TPA, which is contrary to the usual 
experience. It is more likely that overexpression f PKC-( leads 
to a constitutive expression of ST2/T1, which can be further 
enhanced upon stimulation of the endogenous PKC-~. It can- 
not be ruled out as yet that PKC-( can be activated by still 
unknown pathways (e.g. via phosphorylation byother kinases 
that are stimulated by TPA in vivo). 
So far, only one report in the literature [27] showed clear 
differences in transcriptional ctivation of a reporter gene 
under the influence of SRE. The use of additional primers or 
other cell lines in PCR display should enable us and others to 
identify other genes that are differentially regulated by the 
different PKC isozymes. Cloning of their promoters hould 
reveal the elements involved in PKC isozyme-specific regula- 
tion of transcription. 
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